https://gioncologynow.com/videos/dr-christopher-lieu-on-the-importance-of-liver-cancer-awareness-month2026-08-06T17:39:12+00:00https://gioncologynow.com/videos/dr-christopher-lieu-on-the-next-frontier-of-liver-cancer-therapy2026-08-06T17:39:13+00:00https://gioncologynow.com/videos/identifying-hr-and-ner-deficiencies-in-gastric-cancer-for-targeted-treatment-strategies2026-08-06T17:39:13+00:00https://gioncologynow.com/videos/platinum-chemotherapy-parp-inhibitors-for-gastric-or-esophageal-cancers2026-08-06T17:39:13+00:00https://gioncologynow.com/videos/giovanni-di-napoli-medtronic-discusses-an-intelligent-endoscopy-module-that-helps-prevent-colorectal-cancer2026-08-06T17:39:13+00:00https://gioncologynow.com/videos/gi-asco-2023-highlights-with-dr-mark-lewis2026-08-06T17:39:14+00:00https://gioncologynow.com/videos/upper-gastrointestinal-cancer-algorithm2026-08-06T17:39:14+00:00https://gioncologynow.com/videos/neoadjuvant-immunotherapy-demonstrates-promising-results-in-colon-cancer2026-08-06T17:39:14+00:00https://gioncologynow.com/videos/mountaineer-study-an-effective-treatment-combination-for-metastatic-colorectal-cancer2026-08-06T17:39:14+00:00https://gioncologynow.com/videos/using-an-algorithm-to-determine-the-right-colon-cancer-treatment2026-08-06T17:39:15+00:00https://gioncologynow.com/videos/dr-cathy-eng-discusses-fresco-2-trial-and-fruquintinib-for-colorectal-cancer2026-08-06T17:39:15+00:00https://gioncologynow.com/videos/pranob-bhattacharya-discusses-a-potential-new-treatment-option-for-gastric-cancer2026-08-06T17:39:15+00:00https://gioncologynow.com/videos/dr-cathy-eng-discusses-the-fresco-2-study-and-its-impact-on-metastatic-colorectal-cancer-treatment2026-08-06T17:39:15+00:00https://gioncologynow.com/videos/noninvasive-multitarget-stool-rna-test-proves-sensitive-for-colorectal-cancer-advanced-adenomas2026-08-06T17:39:16+00:00https://gioncologynow.com/videos/tace-and-tare-for-unresectable-hcc-history-and-modern-uses2026-08-06T17:39:16+00:00https://gioncologynow.com/videos/tace-and-tare-for-unresectable-hcc-selection-criteria-and-clinical-trial-takeaways2026-08-06T17:39:16+00:00https://gioncologynow.com/videos/sotorasib-plus-panitumumab-in-refractory-kras-g12c-mutated-colorectal-cancer2026-08-06T17:39:16+00:00https://gioncologynow.com/videos/tace-plus-camrelizumab-for-treating-advanced-recurrent-unresectable-hcc2026-08-06T17:39:16+00:00https://gioncologynow.com/videos/efficacy-of-liquid-biopsies-using-extracellular-vesicles-for-patients-with-pdac2026-08-06T17:39:17+00:00https://gioncologynow.com/videos/real-world-outcomes-for-patients-with-hcc-receiving-lenvatinib-after-io2026-08-06T17:39:17+00:00https://gioncologynow.com/videos/safety-considerations-prognostic-factors-for-patients-with-hcc-receiving-lenvatinib-after-io2026-08-06T17:39:21+00:00https://gioncologynow.com/videos/the-role-of-hai-pump-in-colorectal-cancer-treatment2026-08-06T17:39:21+00:00https://gioncologynow.com/videos/leap-002-lenvatinib-plus-pembrolizumab-for-first-line-advanced-hcc2026-08-06T17:39:21+00:00https://gioncologynow.com/videos/leap-002-io-vegf-versus-io-io-versus-io-tki2026-08-06T17:39:22+00:00https://gioncologynow.com/videos/analyzing-the-immunotherapy-landscape-for-advanced-hcc2026-08-06T17:39:22+00:00https://gioncologynow.com/videos/biomarkers-of-response-and-sequencing-for-immunotherapy-in-advanced-hcc2026-08-06T17:39:22+00:00https://gioncologynow.com/videos/toxicities-and-duration-of-treatment-for-immunotherapy-in-advanced-hcc2026-08-06T17:39:22+00:00https://gioncologynow.com/videos/ai-as-a-biomarker-for-abrs-in-patients-with-hcc2026-08-06T17:39:23+00:00https://gioncologynow.com/videos/dr-christopher-lieu-on-the-2024-asco-gi-cancers-symposium2026-08-06T17:39:23+00:00https://gioncologynow.com/videos/dr-milind-javle-on-tinengotinib-for-cca-a-phase-ii-clinical-trial-presented-at-asco-gi-20242026-08-06T17:39:23+00:00https://gioncologynow.com/videos/dr-yelena-janjigian-on-the-matterhorn-study-durvalumab-plus-flot-in-gastric-cancer-at-asco-gi-20242026-08-06T17:39:23+00:00https://gioncologynow.com/videos/dr-timothy-brown-on-radiation-plus-atezolizumab-and-bevacizumab-for-advanced-hcc-at-asco-gi-20242026-08-06T17:39:24+00:00https://gioncologynow.com/videos/dr-christopher-lieu-on-the-circulate-north-america-trial-at-asco-gi-20242026-08-06T17:39:24+00:00https://gioncologynow.com/videos/dr-elizabeth-conner-discusses-dcp-as-a-biomarker-for-hepatocellular-carcinoma-at-asco-gi-20242026-08-06T17:39:24+00:00https://gioncologynow.com/videos/dr-ethan-ludmir-overviews-the-extend-trial-at-asco-gi-20242026-08-06T17:39:24+00:00https://gioncologynow.com/videos/dr-amit-mahipal-discusses-liquid-biopsies-for-advanced-cholangiocarcinoma-at-asco-gi-20242026-08-06T17:39:25+00:00https://gioncologynow.com/videos/spark-a-health-data-integration-platform-for-pancreatic-cancer-research2026-08-06T17:39:25+00:00https://gioncologynow.com/videos/checkmate-8hw-nivolumab-plus-ipilimumab-versus-chemotherapy-for-metastatic-colorectal-cancer2026-08-06T17:39:25+00:00https://gioncologynow.com/videos/evaluating-plasma-uracil-concentration-in-patients-without-dpd-deficiency2026-08-06T17:39:25+00:00https://gioncologynow.com/videos/proof-301-infigratinib-versus-gemcitabine-plus-cisplatin-for-cca-with-fgfr2-rearrangements2026-08-06T17:39:26+00:00https://gioncologynow.com/videos/fresco-2-analyzing-fruquintinib-for-refractory-metastatic-colorectal-cancer2026-08-06T17:39:27+00:00https://gioncologynow.com/videos/napoli-3-nalirifox-versus-nab-paclitaxel-gemcitabine-for-metastatic-pancreatic-ductal-adenocarcinoma2026-08-06T17:39:27+00:00https://gioncologynow.com/videos/checkmate-649-3-year-follow-up-nivolumab-plus-chemotherapy-for-advanced-gastric-gastroesophageal-junction-and-esophageal-adenocarcinoma2026-08-06T17:39:27+00:00https://gioncologynow.com/videos/phase-2-trial-of-agent-797-botensilimab-balstilimab-ramucirumab-and-paclitaxel-in-the-second-line-setting-for-gastric-esophageal-and-gastroesophageal-junction-cancer2026-08-06T17:39:28+00:00https://gioncologynow.com/videos/amplify-201-eli-002-2p-vaccine-for-pancreatic-and-colorectal-cancer2026-08-06T17:39:28+00:00https://gioncologynow.com/videos/colorectal-cancer-awareness-month-dr-christopher-lieu-on-ctdna-bespoke-galaxy-and-netter-22026-08-06T17:39:28+00:00https://gioncologynow.com/videos/bespoke-crc-ctdna-for-informing-adjuvant-chemotherapy-in-colorectal-cancer2026-08-06T17:39:28+00:00https://gioncologynow.com/videos/nest-1-neoadjuvant-botensilimab-balstilimab-for-pmmr-mss-colorectal-cancer2026-08-06T17:39:28+00:00https://gioncologynow.com/videos/characterizing-the-heterogeneity-of-primary-tumors-and-advanced-disease-in-intrahepatic-cca2026-08-06T17:39:29+00:00https://gioncologynow.com/videos/local-ablation-in-pancreatic-cancer-ire-versus-sbrt2026-08-06T17:39:29+00:00https://gioncologynow.com/videos/local-ablation-in-pancreatic-cancer-ongoing-trials-and-investigative-directions2026-08-06T17:39:29+00:00https://gioncologynow.com/videos/arc-8-targeting-cd73-inhibition-in-mpdac-with-quemliclustat-and-zimberelimab2026-08-06T17:39:29+00:00https://gioncologynow.com/videos/combining-gemcitabine-with-cxcr4-pd-1-inhibitors-for-pancreatic-ductal-adenocarcinoma2026-08-06T17:39:30+00:00https://gioncologynow.com/videos/lag-3-and-pd-1-inhibitors-for-esophageal-and-gastroesophageal-junction-cancer-a-phase-ib-trial2026-08-06T17:39:30+00:00https://gioncologynow.com/videos/utility-of-adagrasib-plus-cetuximab-in-patients-with-kras-g12c-mutated-metastatic-crc2026-08-06T17:39:30+00:00https://gioncologynow.com/videos/liquid-biopsy-with-biomarker-ca-19-9-accurately-detects-early-stage-pancreatic-cancer2026-08-06T17:39:30+00:00https://gioncologynow.com/videos/sacituzumab-tirumotecan-for-gastric-cancer-with-trop2-expression-the-kl264-01-trial2026-08-06T17:39:31+00:00https://gioncologynow.com/videos/precede-a-global-effort-to-increase-screening-for-high-risk-pancreatic-cancer2026-08-06T17:39:31+00:00https://gioncologynow.com/videos/managing-defective-mismatch-repair-in-gastroesophageal-adenocarcinoma2026-08-06T17:39:31+00:00https://gioncologynow.com/videos/tislelizumab-approved-as-second-line-treatment-for-advanced-metastatic-esophageal-cancer2026-08-06T17:39:31+00:00https://gioncologynow.com/videos/hipec-for-gastric-cancer-patient-selection-recovery-insights-and-guideline-recommendations2026-08-06T17:39:33+00:00https://gioncologynow.com/videos/breaking-down-bemarituzumab-for-gastric-gej-cancer-insights-from-the-fight-trial2026-08-06T17:39:33+00:00https://gioncologynow.com/videos/previewing-asco-2024-a-sneak-peek-into-arc-9-esopec2026-08-06T17:39:34+00:00https://gioncologynow.com/videos/thermal-ablation-versus-surgical-resection-for-small-colorectal-liver-metastases2026-08-06T17:39:34+00:00https://gioncologynow.com/videos/tact-d-determining-ctdna-response-in-patients-with-metastatic-colorectal-cancer2026-08-06T17:39:34+00:00https://gioncologynow.com/videos/early-findings-show-potential-efficacy-safety-of-bxcl701-pembrolizumab-for-metastatic-pdac2026-08-06T17:39:34+00:00https://gioncologynow.com/videos/investigative-safety-clinical-activity-of-car-t-in-metastatic-colorectal-cancer2026-08-06T17:39:35+00:00https://gioncologynow.com/videos/bot-bal-in-mss-crc-efficacy-in-non-liver-metastatic-sites2026-08-06T17:39:35+00:00https://gioncologynow.com/videos/armani-ramucirumab-plus-paclitaxel-as-switch-maintenance-for-advanced-her2-negative-gastric-gej-cancer2026-08-06T17:39:35+00:00https://gioncologynow.com/videos/overall-survival-date-from-codebreak-300-for-kras-g12c-mutated-mcrc2026-08-06T17:39:36+00:00https://gioncologynow.com/videos/checkmate-9dw-ipi-nivo-as-first-line-treatment-for-uhcc2026-08-06T17:39:36+00:00https://gioncologynow.com/videos/advanced-adenomas-and-increased-risk-of-colorectal-cancer-development-and-mortality2026-08-06T17:39:36+00:00https://gioncologynow.com/videos/keynote-966-three-year-follow-up-for-advanced-biliary-tract-cancer2026-08-06T17:39:36+00:00https://gioncologynow.com/videos/pass-01-stratifying-pancreatic-adenocarcinoma-signature-for-treatment2026-08-06T17:39:37+00:00https://gioncologynow.com/videos/utility-of-ctdna-in-early-stage-advanced-colon-cancer2026-08-06T17:39:37+00:00https://gioncologynow.com/videos/commit-applicability-outside-of-liver-metastasis2026-08-06T17:39:37+00:00https://gioncologynow.com/videos/determining-appropriate-treatment-for-stage-4-colon-cancer2026-08-06T17:39:37+00:00https://gioncologynow.com/videos/treating-younger-patients-with-colon-cancer2026-08-06T17:39:38+00:00https://gioncologynow.com/videos/significance-of-esopec-for-esophageal-gej-adenocarcinoma2026-08-06T17:39:38+00:00https://gioncologynow.com/videos/quic-immunotherapy-chemotherapy-combination-for-advanced-btc2026-08-06T17:39:38+00:00https://gioncologynow.com/videos/fda-approves-noninvasive-multitarget-stool-rna-test-for-colorectal-cancer2026-08-06T17:39:43+00:00https://gioncologynow.com/videos/neoadjuvant-pembrolizumab-shows-potential-benefits-in-early-stage-dmmr-msi-high-crc2026-08-06T17:39:44+00:00https://gioncologynow.com/videos/tmd-as-a-prospective-biomarker-for-patients-with-crc2026-08-06T17:39:44+00:00https://gioncologynow.com/videos/colorectal-cancer-recent-changes-in-the-treatment-landscape2026-08-06T17:39:44+00:00https://gioncologynow.com/videos/targeted-therapies-and-drivers-for-treatment-choice-in-colorectal-cancer2026-08-06T17:39:44+00:00https://gioncologynow.com/videos/treatment-considerations-for-oligometastatic-colorectal-cancer2026-08-06T17:39:45+00:00https://gioncologynow.com/videos/incorporating-ctdna-novel-therapies-into-practice-for-colorectal-cancer2026-08-06T17:39:45+00:00https://gioncologynow.com/videos/sequencing-novel-therapies-in-colorectal-cancer2026-08-06T17:39:45+00:00https://gioncologynow.com/videos/future-directions-in-colorectal-cancer-care2026-08-06T17:39:45+00:00https://gioncologynow.com/videos/spotlight-final-os-results-for-zolbetuximab-plus-mfolfox6-in-metastatic-gastric-gej-adenocarcinoma2026-08-06T17:39:46+00:00https://gioncologynow.com/videos/implications-for-targeted-therapy-genomic-profiling-of-usc-pancreatic-tumors2026-08-06T17:39:46+00:00https://gioncologynow.com/videos/anti-ccr8-antibody-demonstrates-promising-results-for-gastric-cancer2026-08-06T17:39:46+00:00https://gioncologynow.com/videos/disparities-in-biomarker-testing-for-metastatic-colorectal-cancer2026-08-06T17:39:46+00:00https://gioncologynow.com/videos/using-machine-learning-models-to-diagnose-monitor-hcc2026-08-06T17:39:47+00:00https://gioncologynow.com/videos/potential-benefits-of-serum-fusion-transcripts-in-hcc2026-08-06T17:39:47+00:00https://gioncologynow.com/videos/examining-the-lifetime-risk-of-gastric-cancer-in-patients-with-cdh1-gene-variants2026-08-06T17:39:47+00:00https://gioncologynow.com/videos/survival-outcomes-of-neoadjuvant-mfolfirinox-for-resectable-pdac2026-08-06T17:39:47+00:00https://gioncologynow.com/videos/dr-joel-rubenstein-on-new-aga-guideline-endoscopic-eradication-therapy-for-barretts-esophagus2026-08-06T17:39:48+00:00https://gioncologynow.com/videos/regorafenib-and-tas102-for-gi-cancers2026-08-06T17:39:48+00:00https://gioncologynow.com/videos/utilizing-tas102-and-regorafenib-for-future-studies2026-08-06T17:39:48+00:00https://gioncologynow.com/videos/tgf-%ce%b2-signaling-pathway-disruption-for-effective-treatment-of-hcc-with-nk-cells2026-08-06T17:39:51+00:00https://gioncologynow.com/videos/first-line-atezolizumab-with-bevacizumab-for-hcc2026-08-06T17:39:51+00:00https://gioncologynow.com/videos/top-5-uses-of-artificial-intelligence-in-gi-medical-oncology2026-08-06T17:39:51+00:00https://gioncologynow.com/videos/colorectal-cancer-screening-shield-and-the-eclipse-study2026-08-06T17:39:52+00:00https://gioncologynow.com/videos/determining-the-optimal-colorectal-cancer-screening-option-for-patients2026-08-06T17:39:52+00:00https://gioncologynow.com/videos/destiny-gastric03-analyzing-trastuzumab-deruxtecan-for-gastric-and-gej-cancers2026-08-06T17:39:52+00:00https://gioncologynow.com/videos/leap-012-pfs-benefit-with-pembrolizumab-levatinib-and-tace-vs-tace-alone2026-08-06T17:39:53+00:00https://gioncologynow.com/videos/esmo24-gi-review-leap-012-topgear-and-emerald2026-08-06T17:39:53+00:00https://gioncologynow.com/videos/preoperative-crt-versus-perioperative-ct-for-gastric-cancer-the-topgear-study2026-08-06T17:39:53+00:00https://gioncologynow.com/videos/asp3082-in-patients-with-solid-tumors-and-kras-g12d-mutations2026-08-06T17:39:53+00:00https://gioncologynow.com/videos/the-polar-study-pembrolizumab-with-olaparib-for-metastatic-pancreatic-cancer2026-08-06T17:39:54+00:00https://gioncologynow.com/videos/the-himalaya-study-stride-for-uhcc-shows-beneficial-5-year-os-results2026-08-06T17:39:54+00:00https://gioncologynow.com/videos/esmo-2024-key-highlights-in-liver-cancer-leap-012-and-imbrave050-discussion2026-08-06T17:39:54+00:00https://gioncologynow.com/videos/impact-of-zolbetuximab-on-gastric-cancer-treatment2026-08-06T17:39:54+00:00https://gioncologynow.com/videos/vitamin-c-plus-gemcitabine-nab-paclitaxel-for-pancreatic-cancer2026-08-06T17:39:55+00:00https://gioncologynow.com/videos/how-the-increasing-incidence-of-pancreatic-cancer-is-linked-to-early-stage-endocrine-cancer2026-08-06T17:39:55+00:00https://gioncologynow.com/videos/niche-3-cabinet-and-other-gi-oncology-updates-from-esmo-20242026-08-06T17:39:55+00:00https://gioncologynow.com/videos/imbrave050-trial-design-adjuvant-therapy-for-early-stage-hepatocellular-carcinoma2026-08-06T17:39:55+00:00https://gioncologynow.com/videos/does-adjuvant-therapy-benefit-high-risk-liver-cancer-patients-insights-from-imbrave0502026-08-06T17:39:56+00:00https://gioncologynow.com/videos/fda-approval-of-tislelizumab-rationale-305-findings-and-implications-for-practice2026-08-06T17:39:56+00:00https://gioncologynow.com/videos/zanidatamab-for-biliary-tract-cancer-the-herizon-trial2026-08-06T17:39:57+00:00https://gioncologynow.com/videos/top-liver-cancer-abstracts-to-watch-at-asco-gi-20252026-08-06T17:39:58+00:00https://gioncologynow.com/videos/asco-gi-studies-to-monitor2026-08-06T17:39:58+00:00https://gioncologynow.com/videos/napoli-3-ugt1a128-polymorphism-and-tolerability-in-patients-with-mpdac-treated-with-nalirifox2026-08-06T17:39:58+00:00https://gioncologynow.com/videos/effect-of-baseline-geriatric-qol-assessments-on-treatment-outcomes-in-the-giant-study2026-08-06T17:39:59+00:00https://gioncologynow.com/videos/napoleon-2-nanoliposomal-irinotecan-and-neutropenia-in-patients-with-pancreatic-cancer2026-08-06T17:39:59+00:00https://gioncologynow.com/videos/checkmate-9dw-8hw-nest-and-bot-bal2026-08-06T17:39:59+00:00https://gioncologynow.com/videos/herizon-btc-302-zanidatamab-for-her2-positive-btc2026-08-06T17:39:59+00:00https://gioncologynow.com/videos/lixumistat-with-gemcitabine-and-nab-paclitaxel-for-advanced-pancreatic-cancer2026-08-06T17:39:59+00:00https://gioncologynow.com/videos/therabionic-p1-a-new-systemic-targeted-therapy-for-advanced-hcc2026-08-06T17:40:00+00:00https://gioncologynow.com/videos/icis-for-advanced-pancreatic-nets-with-high-tmb-and-mmr-alterations2026-08-06T17:40:00+00:00https://gioncologynow.com/videos/asco-gi-featured-voice-dr-supriya-peshin-on-research-women-in-oncology-and-more2026-08-06T17:40:00+00:00https://gioncologynow.com/videos/personalized-care-in-gastric-and-esophageal-cancers-biomarkers-diagnosis-and-treatment-approaches2026-08-06T17:40:01+00:00https://gioncologynow.com/videos/evolving-strategies-for-early-stage-esophageal-cancer-flot-cross-and-immunotherapy2026-08-06T17:40:01+00:00https://gioncologynow.com/videos/navigating-adjuvant-therapies-in-early-stage-esophageal-cancer-the-role-of-io-and-mrd-testing2026-08-06T17:40:01+00:00https://gioncologynow.com/videos/exploring-tislelizumab-and-zolbetuximab-immunotherapy-and-targeted-options-in-gastric-cancer2026-08-06T17:40:01+00:00https://gioncologynow.com/videos/antibody-drug-conjugates-and-immunotherapy-combinations-what-is-next2026-08-06T17:40:02+00:00https://gioncologynow.com/videos/botensilimab-and-balstilimab-for-refractory-mss-mcrc2026-08-06T17:40:02+00:00https://gioncologynow.com/videos/redefining-treatment-paradigms-with-botensilimab-and-balstilimab-for-mcrc2026-08-06T17:40:02+00:00https://gioncologynow.com/videos/checkmate-8hw-nivolumab-plus-ipilimumab-for-msi-h-dmmr-metastatic-colorectal-cancer2026-08-06T17:40:02+00:00https://gioncologynow.com/videos/breakwater-encorafenib-cetuximab-and-chemotherapy-for-mutant-metastatic-colorectal-cancer2026-08-06T17:40:13+00:00https://gioncologynow.com/videos/advancing-gastric-and-esophageal-cancer-treatment-with-biomarker-driven-strategies2026-08-06T17:40:13+00:00https://gioncologynow.com/videos/the-role-of-ctdna-claudin-18-2-and-pd-l1-in-patient-centered-gastric-cancer-care2026-08-06T17:40:13+00:00https://gioncologynow.com/videos/antibody-drug-conjugates-for-gastric-and-esophageal-cancers-expert-insights2026-08-06T17:40:13+00:00https://gioncologynow.com/videos/challenges-prognosis-and-future-directions-for-peritoneal-gastric-cancer2026-08-06T17:40:14+00:00https://gioncologynow.com/videos/breakwater-new-standard-of-care-frontline-regimen-for-braf-v600e-mutant-mcrc2026-08-06T17:40:14+00:00https://gioncologynow.com/videos/checkmate-8hw-nivo-ipi-versus-nivo-alone-for-msi-h-dmmr-mcrc2026-08-06T17:40:14+00:00https://gioncologynow.com/videos/checkmate-9dw-expanded-analyses-nivo-ipi-versus-len-sor-as-1l-therapy-for-uhcc2026-08-06T17:40:14+00:00https://gioncologynow.com/videos/whats-next-for-adjuvant-therapy-in-liver-cancer-reflections-on-imbrave050-and-beyond2026-08-06T17:40:14+00:00https://gioncologynow.com/videos/investigating-novel-immunotherapy-combinations-for-advanced-gastric-and-esophageal-cancers2026-08-06T17:40:15+00:00https://gioncologynow.com/videos/mek-inhibitor-based-therapy-for-metastatic-pancreatic-cancer-with-kras-g12r-mutations2026-08-06T17:40:15+00:00https://gioncologynow.com/videos/mek-inhibitors-for-mutated-pancreatic-cancer-safety-efficacy-and-combinations2026-08-06T17:40:15+00:00https://gioncologynow.com/videos/kras-g12r-mutations-in-pancreatic-cancer-research-considerations-and-next-steps2026-08-06T17:40:15+00:00https://gioncologynow.com/videos/subcutaneous-nivolumab-for-gastric-cancer-practice-changing-potential2026-08-06T17:40:16+00:00https://gioncologynow.com/videos/breaking-down-destiny-gastric04-and-matterhorn-key-updates-in-gastric-cancer2026-08-06T17:40:16+00:00https://gioncologynow.com/videos/early-onset-crc-factors-education-and-prevention2026-08-06T17:40:16+00:00https://gioncologynow.com/videos/detecting-early-recurrence-with-ctdna-in-btc-after-curative-resection2026-08-06T17:40:16+00:00https://gioncologynow.com/videos/breakwater-trial-signals-new-first-line-option-for-braf-v600e-crc2026-08-06T17:40:17+00:00https://gioncologynow.com/videos/checkmate-8hw-nivolumab-ipilimumab-shows-durable-pfs-benefit-in-msi-h-dmmr-crc2026-08-06T17:40:17+00:00https://gioncologynow.com/videos/can-aspirin-prevent-recurrence-in-early-stage-colorectal-cancer-insights-from-the-alascca-study2026-08-06T17:40:17+00:00https://gioncologynow.com/videos/efficacy-of-zenocutuzumab-in-nrg1-fusion-positive-pancreatic-cancer2026-08-06T17:40:19+00:00https://gioncologynow.com/videos/zenocutuzumab-for-pancreatic-cancer-toxicity-concerns-and-ongoing-research2026-08-06T17:40:20+00:00https://gioncologynow.com/videos/keynote-811-dr-yelena-janjigian-on-pembrolizumabs-fda-approval-for-gastric-gej-cancer2026-08-06T17:40:20+00:00https://gioncologynow.com/videos/5-year-outcomes-of-dynamic-ctdna-guided-adjuvant-therapy-in-colon-cancer2026-08-06T17:40:20+00:00https://gioncologynow.com/videos/ctdna-guided-immunotherapy-a-new-era-of-gastric-cancer-recurrence-prevention2026-08-06T17:40:20+00:00https://gioncologynow.com/videos/top-3-precision-targets-for-metastatic-colorectal-cancer2026-08-06T17:40:20+00:00https://gioncologynow.com/videos/top-3-liver-directed-therapies-for-colorectal-cancer-metastases2026-08-06T17:40:21+00:00https://gioncologynow.com/videos/immunotherapy-in-hcc-selecting-the-right-option-for-the-right-patient2026-08-06T17:40:21+00:00https://gioncologynow.com/videos/cassandra-neoadjuvant-paxg-versus-mfolfirinox-for-resectable-borderline-resectable-pdac2026-08-06T17:40:21+00:00https://gioncologynow.com/videos/elraglusib-with-gem-nab-paclitaxel-for-previously-untreated-metastatic-pancreatic-cancer2026-08-06T17:40:21+00:00https://gioncologynow.com/videos/leap-002-long-term-follow-up-further-exploring-lenvatinib-plus-pembrolizumab-for-liver-cancer2026-08-06T17:40:21+00:00https://gioncologynow.com/videos/herizon-btc-01-vs-a-real-world-control-arm-comparing-zanidatamab-with-chemotherapy-for-biliary-tract-cancer2026-08-06T17:40:22+00:00https://gioncologynow.com/videos/checkmate-577-adjuvant-nivolumab-plus-neoadjuvant-chemoradiotherapy-for-esophageal-and-gastroesophageal-cancer2026-08-06T17:40:22+00:00https://gioncologynow.com/videos/atomic-adjuvant-chemo-alone-with-atezo-for-patients-with-stage-iii-dmmr-colon-cancer2026-08-06T17:40:22+00:00https://gioncologynow.com/videos/matterhorn-practice-changing-treatment-paradigm-for-resectable-g-gej-cancers2026-08-06T17:40:22+00:00https://gioncologynow.com/videos/dynamic-iiis-ctdna-positive-cohort-utilizing-ctdna-to-guide-adjuvant-chemotherapy-escalation-in-patients-with-stage-iii-colon-cancer2026-08-06T17:40:22+00:00https://gioncologynow.com/videos/tumor-treating-fields-combined-with-gemcitabine-and-nab-paclitaxel-for-locally-advanced-pancreatic-cancer-panova-3-trial2026-08-06T17:40:23+00:00https://gioncologynow.com/videos/developing-a-novel-predictive-model-to-predict-regorafenib-response-in-patients-with-metastatic-colorectal-cancer2026-08-06T17:40:23+00:00https://gioncologynow.com/videos/destiny-gastric04-analyzing-the-role-of-t-dxd-in-second-line-her2-gastric-cancer-treatment2026-08-06T17:40:23+00:00https://gioncologynow.com/videos/inside-matterhorn-immunotherapys-role-in-early-stage-gastric-gej-cancer2026-08-06T17:40:23+00:00https://gioncologynow.com/videos/immunotherapy-in-hcc-navigating-combinations-patient-selection-and-evolving-opportunities2026-08-06T17:40:25+00:00https://gioncologynow.com/videos/colosense-included-in-nccn-guidelines-for-colorectal-cancer-screening2026-08-06T17:40:25+00:00https://gioncologynow.com/videos/aspirin-ngs-msi-whats-new-in-crc-testing2026-08-06T17:40:25+00:00https://gioncologynow.com/videos/the-case-for-dual-i-o-in-msi-high-mcrc-is-two-better-than-one2026-08-06T17:40:25+00:00https://gioncologynow.com/videos/redefining-treatment-for-msi-high-crc-neoadjuvant-io-niche-and-non-operative-pathways2026-08-06T17:40:25+00:00https://gioncologynow.com/videos/breakwater-breakthrough-a-new-era-for-braf-v600e-crc2026-08-06T17:40:26+00:00https://gioncologynow.com/videos/from-prognostic-to-predictive-can-ctdna-drive-adjuvant-therapy-decisions2026-08-06T17:40:26+00:00https://gioncologynow.com/videos/personalizing-perioperative-care-experts-react-to-matterhorn-data2026-08-06T17:40:26+00:00https://gioncologynow.com/videos/making-sense-of-flot-durvalumab-and-the-role-of-real-world-tumor-biology2026-08-06T17:40:26+00:00https://gioncologynow.com/videos/flot-d-flot-and-beyond-what-comes-after-matterhorn2026-08-06T17:40:27+00:00https://gioncologynow.com/videos/reflex-rebiopsy-and-response-biomarker-driven-precision-in-metastatic-gastric-cancer2026-08-06T17:40:27+00:00https://gioncologynow.com/videos/managing-esophageal-squamous-immunotherapy-nuances-and-real-world-practice2026-08-06T17:40:27+00:00https://gioncologynow.com/videos/evolving-options-in-hcc-ipi-nivo-atezo-bev-and-stride-in-focus2026-08-06T17:40:27+00:00https://gioncologynow.com/videos/efficacy-without-approval-the-uncertain-place-of-len-pembro-in-hcc2026-08-06T17:40:27+00:00https://gioncologynow.com/videos/from-prolonging-life-to-pursuing-cure-how-immunotherapy-is-shifting-expectations2026-08-06T17:40:28+00:00https://gioncologynow.com/videos/it-takes-a-team-managing-hcc-across-stages-and-specialties2026-08-06T17:40:28+00:00https://gioncologynow.com/videos/the-biomarker-black-hole-in-hcc-where-are-we-now2026-08-06T17:40:28+00:00https://gioncologynow.com/videos/matterhorn-atomic-challenge-and-more-gi-oncology-updates-from-asco-20252026-08-06T17:40:28+00:00https://gioncologynow.com/videos/breakwater-advances-dr-scott-kopetz-on-first-line-therapy-for-braf-v600e-mutated-mcrc2026-08-06T17:40:28+00:00https://gioncologynow.com/videos/from-frontline-to-adjuvant-dr-laura-goff-on-the-expanding-role-and-limits-of-immunotherapy-in-hcc2026-08-06T17:40:28+00:00https://gioncologynow.com/videos/top-5-highest-impact-studies-from-asco-20252026-08-06T17:40:48+00:00https://gioncologynow.com/videos/redefining-adjuvant-therapy-the-atomic-trial-and-a-new-standard-for-dmmr-colon-cancer2026-08-06T17:40:48+00:00https://gioncologynow.com/videos/targeted-and-immuno-oncology-advances-in-mcrc-breakwater-checkmate-8hw-and-challenge2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/nonoperative-care-for-dmmr-rectal-cancer-and-new-frontlines-in-anal-cancer2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/targeting-vegf-pathways-in-advanced-nets-ramucirumab-plus-somatostatin-analog-therapy2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/from-atomic-to-cassandra-landmark-data-across-the-gi-oncology-spectrum2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/early-detection-better-decisions-ctdna-as-a-tool-for-curative-hcc-management2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/intercept-tt-trial-exploring-tas-102-in-crc-patients-with-ctdna-defined-minimal-residual-disease-after-adjuvant-therapy2026-08-06T17:40:49+00:00https://gioncologynow.com/videos/how-hepatitis-b-and-environmental-carcinogens-boost-the-risk-of-liver-cancer2026-08-06T17:40:50+00:00https://gioncologynow.com/videos/liverti-trial-investigating-domvanalimab-and-zimberelimab-in-anti-pd-1-resistant-hcc2026-08-06T17:40:50+00:00https://gioncologynow.com/videos/the-link-between-epigenetic-alterations-and-colorectal-cancer-development2026-08-06T17:40:50+00:00https://gioncologynow.com/videos/epigenetic-editing-for-colorectal-cancer-limitations-and-potential2026-08-06T17:40:50+00:00https://gioncologynow.com/videos/safety-analysis-of-fresco-2-trial-managing-patients-with-metastatic-colorectal-cancer-22026-08-06T17:40:50+00:00https://gioncologynow.com/videos/understanding-the-current-treatment-challenges-in-gi-stromal-tumors-a-comprehensive-review2026-08-06T17:40:50+00:00https://gioncologynow.com/videos/looking-toward-the-future-improving-gi-stromal-care-for-patients2026-08-06T17:40:51+00:00https://gioncologynow.com/videos/from-trials-to-treatment-real-world-insights-on-immunotherapy-use-in-metastatic-colorectal-cancer2026-08-06T17:40:51+00:00https://gioncologynow.com/videos/exploring-neoadjuvant-chemotherapy-in-synchronous-colorectal-liver-metastases2026-08-06T17:40:51+00:00https://gioncologynow.com/videos/phase-ii-maibe-trial-results-maximal-ablative-irradiation-in-locally-advanced-pancreatic-cancer2026-08-06T17:40:51+00:00https://gioncologynow.com/videos/stellar-303-impact-of-zanzalintinib-atezolizumab-for-metastatic-colorectal-cancer2026-08-06T17:40:54+00:00https://gioncologynow.com/videos/efficacy-safety-of-212pb-dotamtate-in-patients-with-unresectable-or-metastatic-gep-nets2026-08-06T17:40:54+00:00https://gioncologynow.com/videos/chief-extended-follow-up-of-atezo-bev-in-advanced-hcc2026-08-06T17:40:54+00:00https://gioncologynow.com/videos/virage-nab-paclitaxel-and-gemcitabine-with-without-vcn-01-in-patients-with-mpdac2026-08-06T17:40:54+00:00https://gioncologynow.com/videos/panova-3-post-hoc-extended-ttfields-use-associated-with-improved-survival-in-patients-with-pancreatic-cancer2026-08-06T17:40:54+00:00https://gioncologynow.com/videos/exploring-divarasib-in-pancreatic-and-cholangiocarcinoma-next-gen-kras-g12c-inhibition-in-rare-cancers2026-08-06T17:40:55+00:00https://gioncologynow.com/videos/breakwater-ctdna-analysis-of-braf-v600e-mutations-in-metastatic-colorectal-cancer2026-08-06T17:40:55+00:00https://gioncologynow.com/videos/adding-ipilimumab-to-atezolizumab-and-bevacizumab-in-unresectable-liver-cancer-the-triplet-hcc-study2026-08-06T17:40:55+00:00https://gioncologynow.com/videos/nom-era-trial-ctdna-and-nonoperative-management-in-rectal-cancer-care2026-08-06T17:40:55+00:00https://gioncologynow.com/videos/short-vs-long-course-radiation-personalizing-rectal-cancer-treatment2026-08-06T17:40:55+00:00https://gioncologynow.com/videos/destiny-gastric04-data-trastuzumab-deruxtecan-vs-ramucirumab-paclitaxel-improves-overall-survival-in-her2-metastatic-gastric-and-gej-adenocarcinoma2026-08-06T17:40:56+00:00https://gioncologynow.com/videos/peptide-receptor-radionuclide-therapy-for-gep-nets-efficacy-and-adoption-in-care2026-08-06T17:40:56+00:00https://gioncologynow.com/videos/esmo-research-highlights-niche-2-and-foxtrot-telisotuzumab-adizutecan-and-more2026-08-06T17:40:56+00:00https://gioncologynow.com/videos/from-event-free-to-overall-survival-the-matterhorn-trial-and-the-future-of-perioperative-immunotherapy2026-08-06T17:40:56+00:00https://gioncologynow.com/videos/advancing-immunotherapy-understanding-tislelizumabs-role-in-advanced-gastric-and-gej-cancer2026-08-06T17:40:56+00:00https://gioncologynow.com/videos/advancing-targeted-therapy-exploring-the-horizon-study-and-novel-her2-strategies-in-gastric-cancer2026-08-06T17:40:57+00:00https://gioncologynow.com/videos/precision-in-practice-integrating-biomarkers-into-perioperative-decision-making2026-08-06T17:40:57+00:00https://gioncologynow.com/videos/beyond-pd-1-the-evolving-role-of-tigit-and-dual-checkpoint-inhibition-in-upper-gi-cancers2026-08-06T17:40:57+00:00https://gioncologynow.com/videos/from-progress-to-promise-advancing-biomarkers-adcs-and-the-next-wave-of-innovation2026-08-06T17:40:57+00:00https://gioncologynow.com/videos/metastatic-colorectal-and-gastric-cancer-key-takeaways-from-esmo-20252026-08-06T17:40:57+00:00https://gioncologynow.com/videos/recent-advancements-in-the-field-of-hepatocellular-carcinoma2026-08-06T17:40:59+00:00https://gioncologynow.com/videos/radiomics-for-monitoring-the-tumor-microenvironment-in-hcc2026-08-06T17:40:59+00:00https://gioncologynow.com/videos/the-potential-of-radiomics-use-in-routine-practice-for-hcc-care2026-08-06T17:40:59+00:00https://gioncologynow.com/videos/himalaya-the-long-term-efficacy-of-stride-over-sorafenib-for-hcc2026-08-06T17:40:59+00:00https://gioncologynow.com/videos/first-in-human-study-of-temab-a-antibody-drug-conjugate-targeting-c-met-in-colorectal-cancer2026-08-06T17:41:00+00:00https://gioncologynow.com/videos/temab-a-plus-bevacizumab-in-colorectal-cancer-safety-efficacy-and-next-steps2026-08-06T17:41:00+00:00https://gioncologynow.com/videos/advancing-colorectal-cancer-care-through-precision-genomics2026-08-06T17:41:00+00:00https://gioncologynow.com/videos/from-liver-to-colorectal-cancer-emerging-immunotherapy-and-precision-medicine-trends2026-08-06T17:41:00+00:00https://gioncologynow.com/videos/expanding-liver-transplant-eligibility-through-immunotherapy-and-robotics2026-08-06T17:41:01+00:00https://gioncologynow.com/videos/navigating-transplant-oncology-for-cholangiocarcinoma-where-genomic-profiling-fits-in2026-08-06T17:41:01+00:00https://gioncologynow.com/videos/advancing-resectable-gastroesophageal-cancer-care-io-integration-and-precision-driven-strategies2026-08-06T17:41:01+00:00https://gioncologynow.com/videos/shaping-the-future-of-gi-research-at-houston-methodist-translational-strategy-and-emerging-innovations2026-08-06T17:41:01+00:00https://gioncologynow.com/videos/targeting-b-cells-to-enhance-io-emerging-evidence-and-future-directions-in-liver-cancer2026-08-06T17:41:01+00:00https://gioncologynow.com/videos/integrating-rlt-in-gep-nets-care-evidence-sequencing-and-the-patient-perspective2026-08-06T17:41:02+00:00https://gioncologynow.com/videos/optimizing-rlt-sequencing-practical-guidance-and-future-directions-in-gep-nets2026-08-06T17:41:02+00:00https://gioncologynow.com/videos/transforming-early-stage-hepatobiliary-cancer-care-with-robotic-and-image-guided-surgery2026-08-06T17:41:02+00:00https://gioncologynow.com/videos/pushing-the-boundaries-in-liver-cancer-multidisciplinary-innovation-at-the-gi-oncology-summit2026-08-06T17:41:02+00:00https://gioncologynow.com/videos/msi-high-colorectal-cancer-and-emerging-immunotherapy-strategies2026-08-06T17:41:02+00:00https://gioncologynow.com/videos/inside-the-houston-methodist-gi-oncology-summit-breakthroughs-and-collaboration-in-20252026-08-06T17:41:03+00:00https://gioncologynow.com/videos/expanding-participation-and-collaboration-at-the-gi-oncology-summit2026-08-06T17:41:03+00:00https://gioncologynow.com/videos/advancing-gi-cancer-care-translational-research-and-clinical-trials-at-the-gi-oncology-summit2026-08-06T17:41:16+00:00https://gioncologynow.com/videos/a-novel-kras-g12d-inhibitor-for-advanced-metastatic-pdac2026-08-06T17:41:16+00:00https://gioncologynow.com/videos/ilustro-zolbetuximab-plus-mfolfox6-nivolumab-for-cldn18-2-advanced-mg-gej-cancer2026-08-06T18:45:13+00:00https://gioncologynow.com/videos/breakwater-primary-analysis-of-1l-encorafenib-plus-cetuximab-folfiri-in-braf-v600e-mutant-mcrc2026-08-06T17:41:17+00:00https://gioncologynow.com/videos/herizon-gea-01-zanidatamab-plus-chemo-tislelizumab-for-1l-her2-positive-locally-advanced-unresectable-or-metastatic-gastroesphogeal-adenocarinoma2026-08-06T17:41:17+00:00https://gioncologynow.com/videos/breakwater-subgroup-analyses-of-age-in-patients-with-braf-v600e-mutant-mcrc2026-08-06T17:41:17+00:00https://gioncologynow.com/videos/results-from-the-1801-part-3b-study-of-elraglusib-plus-gnp-in-previously-untreated-mpdac2026-08-06T17:41:17+00:00https://gioncologynow.com/videos/herizon-btc-01-post-hoc-analysis-of-os-by-objective-response-in-patients-with-previously-treated-advanced-her2-positive-btc2026-08-06T17:41:17+00:00https://gioncologynow.com/videos/keynote-937-adjuvant-pembro-for-patients-with-hcc-radiologic-response-after-resection-or-ablation2026-08-06T17:41:18+00:00https://gioncologynow.com/videos/origami-1-long-term-follow-up-of-amivantamab-plus-folfox-or-folfiri-in-ras-braf-wild-type-mcrc2026-08-06T17:41:18+00:00https://gioncologynow.com/videos/twinpeak-spevatamig-in-combination-with-gnp-for-1l-treatment-of-mpdac2026-08-06T17:41:18+00:00https://gioncologynow.com/videos/commit-atezolizumab-montherapy-versus-mfolfox6-bev-atezo-in-the-1l-treatment-of-patients-with-dmmr-or-msi-h-mcrc2026-08-06T17:41:18+00:00https://gioncologynow.com/videos/circulating-free-rna-as-a-predictive-tool-for-io-benefit-in-dmmr-crc2026-08-06T17:41:18+00:00https://gioncologynow.com/videos/io-combination-approaches-versus-tki-monotherapy-for-the-treatment-of-hcc2026-08-06T17:41:19+00:00https://gioncologynow.com/videos/subgroup-insights-from-the-matterhorn-trial-durvalumab-plus-flot-in-resectable-g-gej-adenocarcinoma2026-08-06T17:41:19+00:00https://gioncologynow.com/videos/key-abstracts-from-asco-gi-20262026-08-06T17:41:19+00:00https://gioncologynow.com/videos/cholangiocarcinoma-awareness-month-exploring-challenges-progress-and-a-new-global-trial2026-08-06T17:41:19+00:00https://gioncologynow.com/videos/evaluating-a-tissue-free-ctdna-assay-to-guide-postoperative-treatment-decisions-in-stage-iii-colon-cancer2026-08-06T17:41:19+00:00https://gioncologynow.com/videos/decoding-ilustro-efficacy-signals-limitations-and-future-directions-in-claudin-18-2-therapy2026-08-06T17:41:20+00:00https://gioncologynow.com/videos/a-new-era-for-her2-positive-gastric-cancer-herizon-gea-01-explained2026-08-06T17:41:20+00:00https://gioncologynow.com/videos/neoadjuvant-chemotherapy-versus-upfront-surgery-for-locally-advanced-colon-cancer2026-08-06T17:41:26+00:00https://gioncologynow.com/videos/finding-signals-in-mss-mcrc-insights-from-a-phase-ii-combination-trial2026-08-06T17:41:27+00:00https://gioncologynow.com/videos/advancing-immunotherapy-in-mcrc-il-12-and-hepatic-artery-infusion-pump-therapy2026-08-06T17:41:27+00:00https://gioncologynow.com/videos/health-related-quality-of-life-and-overall-survival-in-advanced-pancreatic-cancer2026-08-06T17:41:27+00:00https://gioncologynow.com/videos/when-timing-matters-most-ctdna-as-a-prognostic-biomarker-in-localized-colorectal-cancer2026-08-06T17:41:27+00:00https://gioncologynow.com/videos/cytoreductive-surgery-plus-hipec-for-pancreatic-cancer-with-peritoneal-metastasis-feasibility-safety-and-survival2026-08-06T17:41:28+00:00https://gioncologynow.com/videos/why-ngs-and-targeted-therapies-remain-underused-in-metastatic-biliary-tract-cancer2026-08-06T17:41:28+00:00https://gioncologynow.com/videos/inside-the-kras-vaccine-strategy-transforming-adjuvant-therapy-for-pdac2026-08-06T17:41:28+00:00https://gioncologynow.com/videos/closing-the-surveillance-gap-why-ctdna-matters-after-curative-treatment-for-hcc2026-08-06T17:41:28+00:00https://gioncologynow.com/videos/molecular-recurrence-in-hcc-opportunities-limits-and-next-steps-for-ctdna2026-08-06T17:41:28+00:00https://gioncologynow.com/videos/precision-medicine-in-hcc-and-btc-biomarkers-io-combinations-and-treatment-sequencing2026-08-06T17:41:29+00:00https://gioncologynow.com/videos/navigating-ctdna-and-immunotherapy-in-modern-colorectal-cancer-care2026-08-06T17:41:29+00:00https://gioncologynow.com/videos/redefining-gi-oncology-kras-advances-early-onset-crc-and-translational-science2026-08-06T17:41:29+00:00https://gioncologynow.com/videos/fgfr2-targeted-therapy-in-cholangiocarcinoma-findings-from-proof-3012026-08-06T17:41:29+00:00https://gioncologynow.com/videos/degrading-kras-g12d-what-setidegrasib-could-mean-for-the-pancreatic-cancer-treatment-landscape2026-08-06T17:41:30+00:00https://gioncologynow.com/videos/pembrolizumab-and-olaparib-maintenance-in-pancreatic-cancer-interpreting-the-polar-data2026-08-06T17:41:30+00:00https://gioncologynow.com/videos/doubling-survival-in-a-decade-stagnant-disease-inside-the-rasolute-302-topline-results2026-08-06T17:41:30+00:00https://gioncologynow.com/videos/from-signal-to-strategy-how-ctdna-is-reshaping-decision-making-in-mcrc2026-08-06T17:41:30+00:00https://gioncologynow.com/videos/how-reliable-is-ctdna-in-mcrc-understanding-false-negatives-assay-design-and-real-world-use2026-08-06T17:41:31+00:00https://gioncologynow.com/videos/checkmate-9dw-4-year-follow-up-on-overall-survival-by-depth-of-response-and-outcomes-in-long-term-survivors2026-08-06T17:41:31+00:00https://gioncologynow.com/videos/napoli-2-final-results-of-fluorouracil-leucovorin-and-nanoliposomal-irinotecan-in-previously-treated-biliary-tract-cancer2026-08-06T17:41:41+00:00https://gioncologynow.com/videos/interpreting-imbrave251-second-line-treatment-after-atezolizumab-plus-bevacizumab2026-08-06T17:41:41+00:00https://gioncologynow.com/videos/exploring-durvalumab-or-pembrolizumab-added-to-gem-cis-in-advanced-cholangiocarcinoma2026-08-06T17:41:41+00:00https://gioncologynow.com/videos/spevatamig-combination-therapy-in-metastatic-pancreatic-cancer2026-08-06T17:41:41+00:00https://gioncologynow.com/videos/tunlametinib-plus-vemurafenib-in-patients-with-previously-treated-brafv600e-mutant-mcrc2026-08-06T17:41:42+00:00https://gioncologynow.com/videos/tislelizumab-plus-cetuximab-and-irinotecan-in-relapsed-refractory-ras-braf-wild-type-and-mss-mcrc2026-08-06T17:41:42+00:00https://gioncologynow.com/videos/rasolute-302-daraxonrasib-versus-chemo-in-previously-treated-mpdac2026-08-06T17:41:42+00:00https://gioncologynow.com/videos/bayonet-encorafenib-binimetinib-cetuximab-following-encorafenib-cetuximab-for-brafv600e-mutant-mcrc2026-08-06T17:41:42+00:00https://gioncologynow.com/videos/tresbien-encorafenib-binimetinib-and-cetuximab-for-early-relapsed-stage-ii-iii-brafv600e-mutated-crc2026-08-06T17:41:43+00:00https://gioncologynow.com/videos/crdf-004-onvansertib-plus-soc-chemo-plus-bevacizumab-in-first-line-ras-mutated-mcrc2026-08-06T17:41:43+00:00https://gioncologynow.com/videos/secondary-analyses-from-the-phase-1b-2-origami-1-study2026-08-06T17:41:43+00:00https://gioncologynow.com/videos/codebreak-300-ctdna-clearance-as-an-early-indicator-of-sotorasib-panitumumab-efficacy-and-prognosis-in-kras-g12c-mcrc2026-08-06T17:41:43+00:00https://gioncologynow.com/videos/cabozantinib-across-functional-and-non-functional-nets-insights-from-cabinet2026-08-06T17:41:44+00:00https://gioncologynow.com/videos/inbrx-109-ozekibart-combined-with-chemo-in-locally-advanced-or-metastatic-unresectable-crc2026-08-06T17:41:44+00:00https://gioncologynow.com/videos/trident-relacorilant-plus-nab-paclitaxel-gemcitabine-in-patients-with-previously-untreated-mpdac2026-08-06T17:41:44+00:00https://gioncologynow.com/videos/non-operative-management-in-dmmr-esophagogastric-cancer-following-immune-checkpoint-inhibition2026-08-06T17:41:44+00:00https://gioncologynow.com/videos/genomic-profiling-and-response-to-idh1-inhibition-in-cholangiocarcinoma2026-08-06T17:41:45+00:00https://gioncologynow.com/videos/emerald-3-efficacy-and-safety-examining-the-tremelimumab-combo-for-hcc2026-08-06T17:41:45+00:00https://gioncologynow.com/videos/breakwater-pfs-os-analyses-of-encorafenib-cetuximab-folfiri-in-braf-v600e-mutant-mcrc2026-08-06T17:41:45+00:00https://gioncologynow.com/videos/swog-s2107-encorafenib-cetuximab-with-or-without-nivolumab-for-patients-with-previously-treated-mss-braf-v600e-mcrc2026-08-06T17:41:45+00:00https://gioncologynow.com/videos/real-world-outcomes-ctdna-dynamics-in-patients-with-msi-h-mcrc-treated-with-ici2026-08-06T17:41:59+00:00https://gioncologynow.com/videos/cr-sequence-sequencing-panitumumab-versus-bevacizumab-in-mcrc2026-08-06T17:41:59+00:00https://gioncologynow.com/videos/refining-risk-stratification-with-ctdna-in-the-circulate-trial-for-stage-ii-colon-cancer2026-08-06T17:41:59+00:00https://gioncologynow.com/videos/circulate-improved-ttr-and-dfs-in-stage-ii-colon-cancer-with-ctdna-guided-treatment2026-08-06T17:41:59+00:00https://gioncologynow.com/videos/fruquintinib-vs-bevacizumab-in-mcrc-interpreting-non-inferiority-and-clinical-implications2026-08-06T17:41:59+00:00https://gioncologynow.com/videos/real-world-outcomes-and-future-applications-of-ctdna-as-a-biomarker-in-msi-h-mcrc2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/dual-checkpoint-blockade-in-msi-h-mcrc-following-pd-1-progression2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/fgfr-inhibition-vs-gem-cis-in-fgfr2-cholangiocarcinoma-insights-from-real-world-data2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/survival-symptoms-and-whats-next-a-major-shift-in-pancreatic-cancer-treatment2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/rethinking-frontline-crc-powerful-new-options-for-braf-and-beyond2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/evolving-first-line-treatment-in-hcc-io-io-vs-io-vegf-and-early-integration-of-combination-strategies2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/patient-selection-and-safety-considerations-liver-function-portal-hypertension-and-real-world-use-of-immunotherapy2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/emerald-3-and-beyond-advancing-io-based-combinations-with-tace-and-implications-for-treatment-sequencing2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/durable-responses-and-the-tail-of-the-curve-interpreting-long-term-survival-and-treatment-duration-in-hcc2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/response-vs-durability-interpreting-cross-trial-survival-data-to-guide-frontline-therapy-decisions2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/sequencing-and-synergy-multidisciplinary-care-and-the-integration-of-systemic-and-locoregional-therapies2026-08-06T17:42:00+00:00https://gioncologynow.com/videos/redefining-curative-intent-transplant-selection-emerging-strategies-and-the-future-of-hcc-management2026-08-06T17:42:01+00:00https://gioncologynow.com/videos/understanding-the-himalaya-emerald-3-and-sierra-trials-study-designs-and-key-endpoints-in-hcc2026-08-06T17:42:01+00:00https://gioncologynow.com/videos/key-results-and-clinical-implications-of-the-himalaya-emerald-3-and-sierra-trials-in-hcc2026-08-06T17:42:01+00:00https://gioncologynow.com/videos/from-clinical-trials-to-clinical-practice-personalizing-immunotherapy-in-hcc2026-08-06T17:42:01+00:00https://gioncologynow.com/videos/tace-alone-is-not-enough-anymore-what-emerald-3-means-for-liver-cancer-specialists2026-08-06T17:42:09+00:00